Formocresol should be abandoned.
Lewis
Bradley
B
St. Luke's-Roosevelt Hospital Center, New York, USA.
D017607:Aluminum Compounds / Q000627:therapeutic use; D000818:Animals; D017610:Calcium Compounds / Q000627:therapeutic use; D002126:Calcium Hydroxide / Q000627:therapeutic use; D002273:Carcinogens; D004249:DNA Damage; D004338:Drug Combinations; D005290:Ferric Compounds / Q000627:therapeutic use; D005557:Formaldehyde / Q000009:adverse effects*; D005566:Formocresols / Q000009:adverse effects*; D006801:Humans; D009153:Mutagens / Q000009:adverse effects; D010087:Oxides / Q000627:therapeutic use; D011672:Pulpotomy / Q000379:methods*; D017640:Silicates / Q000627:therapeutic use
D017607:Aluminum Compounds; D017610:Calcium Compounds; D002273:Carcinogens; D004338:Drug Combinations; D005290:Ferric Compounds; D005566:Formocresols; D009153:Mutagens; D010087:Oxides; D017640:Silicates; C086631:mineral trioxide aggregate; D005557:Formaldehyde; C031025:formocresol; C024823:ferric sulfate; D002126:Calcium Hydroxide